Patents by Inventor Hong Ma
Hong Ma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20160074437Abstract: Disclosed are means of treatment of liver failure and augmentation of liver regeneration by utilization of immune modulation through administration of immunocytes and mesenchymal stem cells. In one embodiment liver failure is treated by cord blood mononuclear cells administered allogeneic to the host that have been pretreated with hepatogenic cytokines.Type: ApplicationFiled: September 11, 2015Publication date: March 17, 2016Inventors: Samuel C. Wagner, Andy J. Kim, Hong Ma, Dimitri Theofilopoulos
-
Publication number: 20160025070Abstract: A method of calculating theoretical power of wind farm based on extrapolation of anemometer tower data includes following steps. A number of anemometer towers in a wind farm is selected, and analyzing historical data acquired by the number of anemometer towers. An air density is calculated based on the historical data of the number of anemometer towers. A power curve is calibrated based on the historical data of the number of anemometer towers. The power curve is fit based on a wind speed and a wind power of a fan head of each wind turbine based on the historical data. An theoretical power calculation extrapolation model of anemometer tower data is constructed. Real-time anemometer tower wind data and a calibrated air density are inputted into the theoretical power calculation model and calculating the wind power. The theoretical power is obtained.Type: ApplicationFiled: July 27, 2015Publication date: January 28, 2016Inventors: NING-BO WANG, MING MA, QING-QUAN LV, YAN-HONG MA, GUANG-TU LIU, HUAI-SEN JIA, LONG ZHAO, ZI-FEN HAN, QIANG ZHOU, DING-MEI WANG, LIANG LU, JIAN-MEI ZHANG
-
Publication number: 20160025071Abstract: A method of computing theoretical power of wind farm based on sample wind turbine method. Historical real-time measured output data of sample wind turbines in the wind farm is statistically analyzed. A theoretical output of the sample wind turbines is analyzed based on a wind power output characteristic and a theoretical output design curve of wind turbine. A theoretical power calculation model of wind farm is constructed based on the historical real-time measured output data of sample wind turbines. A number of wind turbines actually running in real-time is obtained based on real-time information data of wind turbines in the wind farm. An actual operation data of the sample wind turbines is confirmed. The actual operation data is input into the theoretical power calculation model of wind farm. Real-time data of theoretical power of wind farm is output, and an actual operation result of wind farm is comparatively analyzed.Type: ApplicationFiled: July 27, 2015Publication date: January 28, 2016Inventors: NING-BO WANG, MING MA, QING-QUAN LV, YAN-HONG MA, GUANG-TU LIU, HUAI-SEN JIA, LONG ZHAO, ZI-FEN HAN, QIANG ZHOU, DING-MEI WANG, LIANG LU, JIAN-MEI ZHANG
-
Publication number: 20150241598Abstract: A method of dividing irradiance regions based on rotated empirical orthogonal function includes following steps. A standardized matrix averaging on annual total radiation amount data is performed. An empirical orthogonal function decomposition on an annual total radiation variable field matrix is performed based on the standardized matrix averaging result of the annual total radiation amount data. A variance contribution rate and an accumulative variance contribution rate are calculated by rotating a load matrix and a factor matrix according to a varimax orthogonal rotation principle based on the empirical orthogonal function decomposition result of the annual total radiation variable field matrix. The irradiance regions are divided according to results of the variance contribution rate and the accumulative variance contribution rate.Type: ApplicationFiled: February 11, 2015Publication date: August 27, 2015Inventors: NING-BO WANG, LIANG LU, YAN-HONG MA, QIANG ZHOU, DING-MEI WANG, XU CHENG, LONG ZHAO, KUN DING, SHI-YUAN ZHOU, GUANG-TU LIU, QING-QUAN LV, ZHAO CHEN
-
Publication number: 20150086603Abstract: The present invention relates to implantable medical devices containing surface-treated, dual-targeted drug carriers for treating vascular diseases.Type: ApplicationFiled: December 1, 2014Publication date: March 26, 2015Inventors: Syed F.A. Hossainy, Dariush Davalian, Jinping Wan, Hong Ma
-
Patent number: 8942188Abstract: The present invention relates to a method of reducing beacon collision probability in a communication network supporting control channels comprising beacon periods divided into beacon slots, each beacon period being followed by a contention period. In the method a communication device (101) operating in the communication network first chooses (503) an available beacon slot for transmission of a first type of beacon for exchanging network topology information with other communication devices operating in the communication network. Then the communication device transmits (515) a beacon of a second type comprising an identifier of the communication device and the chosen beacon slot for the transmission of the beacon of the first type, the beacon of the second type being transmitted in the contention period.Type: GrantFiled: August 22, 2008Date of Patent: January 27, 2015Assignee: Koninklijke Philips N.V.Inventors: Hans-Juergen Reumerman, Yunpeng Zang, Lothar Stibor, Bernhard Walke, Hong Ma
-
Publication number: 20140283219Abstract: The present invention provides methods of producing biological products or increasing production of such products through expression in a plant of a bacterial or plant glycolate catabolic cycle gene, such as glycolate dehydrogenease (GDH), glycolate oxidase (GO), or malate synthase (MS) in combination with a plant gene, such as farnesyl diphosphate synthase (FPS), squalene synthase (SQS), or PLAS. Also provided are plants, plants parts and compositions produced through methods of the present invention. The invention leads to two to five fold increase of end product yield.Type: ApplicationFiled: February 28, 2014Publication date: September 18, 2014Applicants: The Texas A&M University System, The University of Illinois at Urbana Champaign, University of KentuckyInventors: Shuhua (Joshua) Yuan, Donald Ort, Joseph Chappell, Xinguang Zhu, Hong Ma, Yong Kyoung Kim
-
Publication number: 20140199377Abstract: Disclosed are compositions with sustained-release carriers associated with at least two different types of growth factors and methods of fabrication and treatments thereof. In some embodiments, simultaneous release of the growth factors may be preferred while in other embodiments, sequential release of the growth factors may be preferred. Application of at least two growth factors to an injury site, e.g., compromised cardiac tissue caused by, for example, myocardial infarction or ischemic heart failure, may better mimic and induce the complex growth factor signaling pathways necessary to improve cardiac function. When applied to a patient after a myocardial infarction or ischemic heart failure, multiple growth factors within a sustained-release carrier platform or platforms may cause a synergistic effect on injected cells intending to alleviate left ventricle remodeling. Methods of treatment include percutaneous, sub-xiphoid, and open chest methods using catheters and/or syringes.Type: ApplicationFiled: March 18, 2014Publication date: July 17, 2014Applicant: Abbott Cardiovascular Systems Inc.Inventors: John J. Stankus, Florian N. Ludwig, Evgenia Mandrusov, Liangxuan Zhang, Hong Ma, Jinping Wan, Shubhayu Basu
-
Patent number: 8703180Abstract: Disclosed are compositions with sustained-release carriers associated with at least two different types of growth factors and methods of fabrication and treatments thereof. In some embodiments, simultaneous release of the growth factors may be preferred while in other embodiments, sequential release of the growth factors may be preferred. Application of at least two growth factors to an injury site, e.g., compromised cardiac tissue caused by, for example, myocardial infarction or ischemic heart failure, may better mimic and induce the complex growth factor signaling pathways necessary to improve cardiac function. When applied to a patient after a myocardial infarction or ischemic heart failure, multiple growth factors within a sustained-release carrier platform or platforms may cause a synergistic effect on injected cells intending to alleviate left ventricle remodeling. Methods of treatment include percutaneous, sub-xiphoid, and open chest methods using catheters and/or syringes.Type: GrantFiled: October 23, 2007Date of Patent: April 22, 2014Assignee: Abbott Cardiovascular Systems Inc.Inventors: John J. Stankus, Florian N. Ludwig, Evgenia Mandrusov, Liangxuan Zhang, Hong Ma, Jinping Wan, Shubhayu Basu
-
Patent number: 8546644Abstract: The invention discloses a recombinant gene which enhances the ability of fish to tolerate low dissolved oxygen (DO) stress and the use thereof. Carp ?-actin gene promoter is used as a promoter and Vitreoscilla hemoglobin gene is used as a target gene, so as to construct the recombinant Vitreoscilla hemoglobin gene driven by carp ?-actin promoter. The modeling organism zebrafish is used as the research object, and the recombinant gene is microinjected into zygotes of zebrafish. After PCR screening and 156 h low DO stress test, transgenic fish are obtained with a survival rate of 92%, which is significantly different from the survival rate of 65% of the control fish group. The vhb transgenic zebrafish obtain hypoxia tolerance. When the recombinant gene is applied to the economically farmed species, i.e., blunt snout bream (Megalobrama amblycephala) and common carp (Cyprinus carpio L.), it enhances their hypoxia tolerance as well.Type: GrantFiled: September 10, 2010Date of Patent: October 1, 2013Assignees: Institute of Hydrobiology, Chinese Academy of Sciences, Peking UniversityInventors: Wei Hu, Zuoyan Zhu, Hong Ma, Bo Guan, Yuanlei Hu, Zhongping Lin
-
Patent number: 8188759Abstract: A method and apparatus for testing a photovoltaic substrate disposes the substrate on a support gantry with connection points such as vacuum cups. The gantry is actuated into a test position. A probe nest coupled to the gantry connects to a junction box on the substrate. A power supply applies voltage to the junction box, and an actuated frame contacts an edge region of the substrate to detect any breakthrough current. The actuated frame comprises a liner for maximizing contact with the edge of the substrate. The liner may be conductive, or may have a conductive surface. Current sensors coupled to the conductive liner of the frame detect any breakthrough current. A solar spectrum simulator provides solar spectrum radiation for testing the photovoltaic properties of the substrate.Type: GrantFiled: September 16, 2009Date of Patent: May 29, 2012Assignee: Applied Materials, Inc.Inventors: Peter Wang, Harry Smith Whitesell, III, Danny Cam Toan Lu, Tzay-Fa Su, Michael Marriott, Xue Hong Ma, Xiao Ning Li, Jie Ling
-
Patent number: 8110342Abstract: A method for forming an opening is disclosed. First, a semiconductor substrate is provided, in which the semiconductor substrate includes at least one metal interconnects therein. A stacked film is formed on the semiconductor substrate, in which the stacked film includes at least one dielectric layer and one hard mask. The hard mask is used to form an opening in the stacked film without exposing the metal interconnects, and the hard mask is removed thereafter. A barrier layer is later deposited on the semiconductor substrate to cover a portion of the dielectric layer and the surface of the metal interconnects.Type: GrantFiled: August 18, 2008Date of Patent: February 7, 2012Assignee: United Microelectronics Corp.Inventors: Feng Liu, Shi-Jie Bai, Hong Ma, Chun-Peng Ng, Ye Wang
-
Patent number: 8101565Abstract: A method including advancing a delivery device through a lumen of a blood vessel to a particular region in the blood vessel; and introducing a composition including a sustained-release carrier and an apolipoprotein A-I (apo A-I) synthetic mimetic peptide into a wall of the blood vessel at the particular region or a perivascular site, wherein the peptide has a property that renders the peptide effective in reverse cholesterol transport. A composition including an apolipoprotein A-I (apo A-I) synthetic peptide, or combination of an apo A-I synthetic mimetic peptide and an Acyl CoA cholesterol: acyltransferase (ACAT) inhibitor in a form suitable for delivery into a blood vessel, the peptide including an amino acid sequence in an order reverse to an order of various apo A-I mimetic peptides, or endogenous apo A-I analogs, or a chimera of helix 1 and helix 9 of endogenous apo A-I.Type: GrantFiled: November 27, 2007Date of Patent: January 24, 2012Assignee: Abbott Cardiovascular Systems Inc.Inventors: Katsuyuki Murase, Syed F. A. Hossainy, Irina Astafieva, Li Zhao, Hong Ma
-
Patent number: 8034712Abstract: A method of fabricating a dual damascene structure is described. A dielectric layer and a metal hard mask layer are sequentially formed on a substrate having thereon a conductive layer and a liner layer. The metal hard mask layer and the dielectric layer are patterned to form a via hole exposing a portion of the liner layer. A gap-filling layer is filled in the via hole, having a height of ¼ to ½ of the depth of the via hole. A trench is formed in the metal hard mask layer and the dielectric layer. The gap-filling layer is removed to expose the portion of the liner layer, which is then removed. A metal layer is formed filling in the via hole and the trench, and then the metal hard mask layer is removed.Type: GrantFiled: October 4, 2010Date of Patent: October 11, 2011Assignee: United Microelectronics Corp.Inventors: Kuang-Yeh Chang, Hong Ma
-
Patent number: 8019457Abstract: A method of controlling a result parameter of an IC manufacturing procedure is described. The value of at least one first variable of a process correlated with the result parameter is acquired, and the difference between the predicted value and the target value of the result parameter is calculated from the same using a correlation equation of the first variable and the result parameter. A correcting action is then performed to a subsequent process including at least one second variable correlated with the result parameter, which is based on a correlation equation of the second variable and the result parameter to control the subsequent process and adjust the second variable such that the difference is reduced due to the affect of the second variable to the result parameter. The at least one first variable and the at least one second variable include two or more different physical quantities.Type: GrantFiled: April 14, 2008Date of Patent: September 13, 2011Assignee: United Microelectronics Corp.Inventor: Hong Ma
-
Patent number: 7989804Abstract: A test pattern structure including a first conductive layer and a second conductive layer is provided. The second conductive layer is directly disposed on the first conductive layer and connected to the first conductive layer through a plurality of connection interfaces. The test pattern structure of the present invention can detect the interconnection failure quickly and correctly without SEM identification.Type: GrantFiled: March 4, 2009Date of Patent: August 2, 2011Assignee: United Microelectronics Corp.Inventors: Da-Jiang Yang, Chih-Ping Lee, Rui-Huang Cheng, Xing-Hua Zhang, Xu Ma, Xiao-Fei Han, Hong Ma, Hong Liao, Yuan-Li Ding
-
Publication number: 20110099648Abstract: The invention discloses a recombinant gene which enhances the ability of fish to tolerate low dissolved oxygen (DO) stress and the use thereof. Carp ?-actin gene promoter is used as a promoter and Vitreoscilla hemoglobin gene is used as a target gene, so as to construct the recombinant Vitreoscilla hemoglobin gene driven by carp ?-actin promoter. The modeling organism zebrafish is used as the research object, and the recombinant gene is microinjected into zygotes of zebrafish. After PCR screening and 156 h low DO stress test, transgenic fish are obtained with a survival rate of 92%, which is significantly different from the survival rate of 65% of the control fish group. The vhb transgenic zebrafish obtain hypoxia tolerance. When the recombinant gene is applied to the economically farmed species, i.e., blunt snout bream (Megalobrama amblycephala) and common carp (Cyprinus carpio L.), it enhances their hypoxia tolerance as well.Type: ApplicationFiled: September 10, 2010Publication date: April 28, 2011Applicants: INSTITUTE OF HYDROBIOLOGY, CHINESE ACADEMY OF SCIENCES, PERKING UNIVERSITYInventors: WEI HU, ZUOYAN ZHU, HONG MA, BO GUAN, YUANLEI HU, ZHONGPING LIN
-
Publication number: 20110026472Abstract: The present invention relates to a method of reducing beacon collision probability in a communication network supporting control channels comprising beacon periods divided into beacon slots, each beacon period being followed by a contention period. In the method a communication device (101) operating in the communication network first chooses (503) an available beacon slot for transmission of a first type of beacon for exchanging network topology information with other communication devices operating in the communication network. Then the communication device transmits (515) a beacon of a second type comprising an identifier of the communication device and the chosen beacon slot for the transmission of the beacon of the first type, the beacon of the second type being transmitted in the contention period.Type: ApplicationFiled: August 22, 2008Publication date: February 3, 2011Applicant: KONINKLIJKE PHILIPS ELECTRONICS N.V.Inventors: Hans-Juergen Reumerman, Yunpeng Zang, Lothar Stibor, Bernhard Walke, Hong Ma
-
Publication number: 20110021021Abstract: A method of fabricating a dual damascene structure is described. A dielectric layer and a metal hard mask layer are sequentially formed on a substrate having thereon a conductive layer and a liner layer. The metal hard mask layer and the dielectric layer are patterned to form a via hole exposing a portion of the liner layer. A gap-filling layer is filled in the via hole, having a height of ¼ to ½ of the depth of the via hole. A trench is formed in the metal hard mask layer and the dielectric layer. The gap-filling layer is removed to expose the portion of the liner layer, which is then removed. A metal layer is formed filling in the via hole and the trench, and then the metal hard mask layer is removed.Type: ApplicationFiled: October 4, 2010Publication date: January 27, 2011Applicant: UNITED MICROELECTRONICS CORP.Inventors: Kuang-Yeh Chang, Hong MA
-
Publication number: 20110003404Abstract: A method and apparatus for testing a photovoltaic substrate disposes the substrate on a support gantry with connection points such as vacuum cups. The gantry is actuated into a test position. A probe nest coupled to the gantry connects to a junction box on the substrate. A power supply applies voltage to the junction box, and an actuated frame contacts an edge region of the substrate to detect any breakthrough current. The actuated frame comprises a liner for maximizing contact with the edge of the substrate. The liner may be conductive, or may have a conductive surface. Current sensors coupled to the conductive liner of the frame detect any breakthrough current. A solar spectrum simulator provides solar spectrum radiation for testing the photovoltaic properties of the substrate.Type: ApplicationFiled: September 16, 2009Publication date: January 6, 2011Applicant: APPLIED MATERIALS, INC.Inventors: Peter Wang, Harry Smith Whitesell, III, Danny Cam Toan Lu, Tzay-Fa Su, Michael Marriot, Xue Hong Ma, Xiaoning Li, Jie Ling